If you or a loved one has a cancer diagnosis, you're likely flooded with information about treatment options. While traditional biopsies remain crucial for definitive diagnosis, a new wave of innovation is transforming the landscape of cancer care.

At RGCC, we're at the forefront of this change, offering a suite of advanced blood tests that provide a deeper understanding of your cancer. Blood tests for cancer have traditionally played a supportive role. However, RGCC's pioneering approach leverages cutting-edge technology and medical advancements to transform them into powerful diagnostic tools.

Explore how our advanced blood tests can empower you and your doctor to make informed decisions about your cancer journey.

Our minimally invasive blood checks for cancer go beyond traditional options, offering valuable information with a simple blood draw. Here is why our tests are changing the paradigm of the traditional cancer treatment approach.

• Faster diagnosis & treatment. Unlike biopsies, blood tests are less time-consuming and don't require tissue samples. This can expedite diagnosis and start of treatment, potentially improving outcomes.
• Reduced discomfort & stress. Biopsies can be uncomfortable and require recovery time. Blood tests eliminate these burdens, allowing for a less stressful experience during your fight against cancer.
• Monitor treatment response. Periodic blood tests allow your doctor to closely monitor your response to treatment. This enables them to identify potential issues early and adjust your treatment plan proactively, maximizing its effectiveness.

While some blood tests can be used to identify tumor markers, indicating a possible presence of cancer, they are not definitive for diagnosis. However, at RGCC, we go beyond traditional blood tests for cancer detection, leveraging cutting-edge technologies, such as:

• Liquid biopsy and CTC tests: RGCC’s liquid biopsies are blood tests that analyze your blood for the presence of circulating tumor cells (CTCs) shed by your cancer. They can potentially identify the presence and characteristics of cancer, even in its early stages. This can enable quicker interventions and an increased chance of treatment success.
• Advanced genetic testing: Our genetic tests for cancer go beyond traditional tumor marker analysis. They delve deeper, revealing the unique genetic and genomic profile of your cancer. This information can be crucial for identifying the specific cancer type and developing a personalized treatment plan tailored to your cancer.

It's important to note that the specific role of RGCC's blood tests for cancer may vary depending on the type and stage of your cancer. However, the potential for earlier and more precise diagnoses and monitoring offered by these tests is an unprecedented advancement in cancer care.

We recommend discussing your specific situation with an RGCC Registered Practitioner to determine how RGCC's blood tests might be suitable for you.

Facing a cancer diagnosis is a life-altering event, and understanding your treatment options becomes crucial. The minimally invasive nature of our blood tests eases the process of extracting valuable insights about your cancer. 

Your practitioner can then leverage this information to carry out regular monitoring of your response to treatment, enabling them to monitor your response to therapy, identify potential issues early on, and adjust your treatment plan proactively. 

Consider exploring our Onconomics Plus test, designed specifically to analyze your cancer's response to various treatment options, including chemotherapy and natural therapies. 

Traditional "one-size-fits-all" cancer treatment approaches are giving way to precision medicine, a strategy that tailors therapies to the specific genetic and genomic makeup of your cancer. Our tests delve deeper than traditional tumor marker analysis, highlighting specific genomic characteristics that drive your cancer's growth and progression. 

This can help identify targeted therapies with a higher chance of success, minimizing the risk of ineffective treatments and potential side effects. For example, the test might reveal your cancer's susceptibility to specific therapies, increasing your success rate.

The fight against cancer doesn't end with completing initial treatment. Early detection of recurrence is crucial for successful long-term management. RGCC's blood tests can help detect CTCs in your bloodstream after treatment to raise an early red flag, prompting further investigation by your practitioner.

The ease of blood tests allows for regular monitoring over time. By tracking CTC levels over time, your practitioner can identify potential increases that might indicate a recurrence early on, allowing for quicker intervention.

By working collaboratively with your practitioner and exploring the possibilities offered by our advanced blood tests, you can empower yourself with a more comprehensive understanding of your cancer and take a proactive approach to your diagnosis and treatment journey.

Discover groundbreaking cancer testing solutions pioneered by RGCC, which throw light on the path toward better cancer care. We offer a paradigm shift in cancer care technologies and protocols.

Our mission is to empower patients with unique insights into their cancer biology, guiding them toward success in their cancer journey.

Get in touch today to start your journey to empowering information for your cancer treatment by contacting us online.